LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Clinical trial NCT04031872 · WITHDRAWN

Trial details

NCT number: NCT04031872
Sponsor: The Netherlands Cancer Institute
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2020-01-01
Primary completion: 2020-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.